Tagged: Research

UCSF School of Pharmacy leads in NIH funding for the 40th straight year

Thu Apr 2, 2020

Susan Merrell

Nadav Ahituv, PhD, right, with postdoctoral scholar Fumitaka Inoue, PhD.

School research into health, disease, and medicine earned the most NIH research dollars of any U.S. pharmacy school—for the 40th consecutive year.

QBI Coronavirus Research Group races toward a cure

Tue Mar 31, 2020

SARS-COV2 virus particles on human cells

NIH

SARS-COV2 virus particles (orange), which cause COVID-19, on human cells (blue).

The UCSF Quantitative Biosciences Institute has made headway identifying dozens of potential therapies for the COVID-19 outbreak.

Hunting for a cure for COVID-19: an insider’s story

Sat Mar 21, 2020

QBI’s director, Nevan Krogan, PhD, left, and Jacqueline Fabius, QBI's chief operating officer

The chief operating officer of the Quantitative Biosciences Institute (QBI) shares a view of the team's work on COVID-19.

2020 Mary Anne Koda-Kimble Seed Award for Innovation fuels vital research across the School

Fri Mar 20, 2020

Mary Anne Koda-Kimble, PharmD, former dean of the School of Pharmacy

The award funds the boldest, riskiest, and most blue-sky ideas.

UCSF features expertise in kidney care and work on artificial kidney

Fri Mar 13, 2020

An illustration of the kidneys inside the body.

crystal light/Shutterstock.com

Kidney disease affects more than 37 million Americans.

A team of kidney experts talk about kidney disease and share their hopes for the future.

Assemi wins award for work on PharmD experiential education

Mon Mar 2, 2020

Elisabeth Fall

Mitra Assemi, PharmD, associate dean of accreditation and quality improvement

Mitra Assemi, PharmD, was honored for her research on the hands-on components of pharmacy curricula around the U.S.

Sample medications and detailing visits add to costs, Guglielmo argues

Wed Jan 29, 2020

Elisabeth Fall

UCSF School of Pharmacy Dean B. Joseph Guglielmo, PharmD

Free samples of medications and “detailing visits” are costly, B. Joseph Guglielmo argues in JAMA.

FDA, academia, and industry join forces to shepherd new therapies to patients

Thu Jan 23, 2020

Noah Berger

Kathy Giacomini, PhD, is co-director of UCSF-Stanford CERSI.

UCSF-Stanford CERSI brings together scientists, industry, and government regulators to get new therapies to patients sooner.

Implantable bioartificial kidney achieves preclinical milestone

Thu Nov 7, 2019

Elisabeth Fall

Shuvo Roy, PhD

Scientists implanted a prototype kidney bioreactor in large animals without significant safety concerns.

VR drug discovery makes precision therapy a reality

Wed Oct 16, 2019

Beth Apsel Winger, MD, PhD (left), and Matthew Jacobson, PhD (right) explore a cancer-causing mutation in a protein in virtual reality, using UCSF ChimeraX.

ChimeraX, virtual reality software developed at the UCSF Resource for Biocomputing, Visualization and Informatics, is now the tool of choice for computational structural biologists in the School of Pharmacy. The Jacobson Lab recently used ChimeraX to find a promising new cure for a drug-resistant...

Pages